Search results for "Older population"

showing 4 items of 24 documents

Periodontal treatment needs and systemic diseases in an older population in Greece

2016

Background: To evaluate the relationship between systemic diseases, body mass index and periodontal treatment needs in an older population in Greece. Material and Methods: A total of 262 older people were clinically examined about their periodontal status and medical histories were recorded using a health history questionnaire. Additionally, weight and height measurements as well as demographic data were obtained from the participants in the study. Results: Older people exhibited mean age of 63.98 years, weight of 78.76 kg and height of 1.64 m. The mean CPITN score was 2.84. 31.7% of the study population were smokers and 53.8% females. No statistically significant difference was observed in…

medicine.medical_specialtyPeriodontal treatmentOsteoporosisOdontologíaOlder population03 medical and health sciences0302 clinical medicineInternal medicineMedicine030212 general & internal medicineGeneral DentistryPeriodontitisbusiness.industryResearchSignificant difference030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludCommunity and Preventive DentistryHealth historyUNESCO::CIENCIAS MÉDICASPhysical therapyPopulation studybusinessBody mass index
researchProduct

Improved Safety with the Use of Subcutaneous Bortezomib in Combination with Panobinostat and Dexamethasone: Preliminary Data from a Panobinostat Glob…

2016

Abstract Introduction: Panobinostat (PAN) is a potent pan-deacetylase inhibitor that targets multiple myeloma (MM) cells via its epigenetic effects as well as its effect on the aggresome. In the PANORAMA 1 phase 3 trial, the combination of PAN, bortezomib (BTZ), and dexamethasone (Dex; PAN+BTZ+Dex) significantly increased progression-free survival compared with placebo plus BTZ and Dex, leading to approval in Europe of the combination for the treatment of patients with MM who have received ≥ 2 prior regimens, including BTZ and an immunomodulatory agent. The purpose of this expanded treatment protocol (ETP) is to further evaluate safety and to provide panobinostat prior to commercial availab…

medicine.medical_specialtyTreatment protocolBortezomibbusiness.industryImmunologyDisease progressionCell BiologyHematologyNeutropeniamedicine.diseaseBiochemistryOlder populationSurgerychemistry.chemical_compoundchemistryTolerabilityInternal medicinePanobinostatmedicinebusinessDexamethasonemedicine.drugBlood
researchProduct

Oral health and dysphagia in the older population: Report of the 2nd EICA-ESSD-EUGMS train the trainers course

2017

The purpose ofthe manuscriptis to summarize the key points of the European Society for Swallowing Disorders (ESSD) course, ‘‘Effective care of older patients with swallowing difficulties’’ organized by the European Interdisciplinary Council of Ageing (EICA) and by the European Union Geriatric Medicine Society (EUGMS)

medicine.medical_specialtybusiness.industryOral healthmedicine.diseaseDysphagiaOlder population03 medical and health sciencesMalnutrition0302 clinical medicineSwallowing problemsOral healtmedicinePhysical therapy030212 general & internal medicineGeriatrics and Gerontologymedicine.symptombusinessGerontology030217 neurology & neurosurgery
researchProduct

Multimorbidity and anxiety symptoms among adults aged 50 years and over from six low- and middle-income countries

2021

Currently, there are limited data on the association between multimorbidity (i.e., ≥ 2 chronic conditions) and anxiety, especially among the older population in low- and middle-income countries (LMICs). Thus, the aim of the present study was to examine the association between multimorbidity and anxiety symptoms in a large sample of adults aged ≥ 50 years from six LMICs (China, India, Ghana, Mexico, Russia, South Africa). Cross-sectional, nationally representative, community-based data from the Study on Global Ageing and Adult Health (SAGE) were analysed. A total of 11 chronic physical conditions were assessed. Anxiety symptoms referred to extreme/severe problems with worry or anxiety in the…

medicine.medical_specialtymultimorbiditybusiness.industrymedia_common.quotation_subjectmulticountryLogistic regressionanxietyOddsOlder populationLow and middle income countriesEpidemiologymedicineAnxietySmıth L. F. López Sánchez G. Shin J. I. Soysal P. Veronese N. -Multimorbidity and Anxiety Symptoms among Adults Aged 50 Years and Over from Six Low- and Middle-Income Countries- Journal of Ageing and Longevity cilt.1 sa.1 ss.36-47 2021epidemiologylow- and middle-income countriesmedicine.symptomWorrybusinessAdult healtholder adultsDemographymedia_common
researchProduct